Lannett Co Inc (LCI)
(Delayed Data from NYSE)
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.54 USD
+0.70 (8.93%)
Updated May 3, 2019 04:00 PM ET
After-Market: $8.54 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Affimed (AFMD) Shows Strength: Stock Moves 8.1% Higher
by Zacks Equity Research
Affimed N.V. (AFMD) shares rise above 8% in the last trading session.
GNC Holdings (GNC) Q4 Earnings: A Surprise in the Cards?
by Zacks Equity Research
GNC Holdings, Inc. (GNC) -- a specialty retailer of health and nutrition related products -- is scheduled to report fourth-quarter 2016 financial results on Feb 16, before the opening bell.
AcelRx Pharmaceuticals (ACRX) in Focus: Stock Rises 5.3%
by Zacks Equity Research
AcelRx Pharmaceuticals, Inc.(ACRX) was a big mover last session, as the company saw its shares rise over 5% on the day.
Endo International (ENDP): Can the Stock Rebound in 2017?
by Zacks Equity Research
Can Endo make a comeback in 2017 seeing that the company is presently in the middle of the drug pricing controversy?
20 States Sue Teva, Mylan & Other Drug Companies for Price Fixing
by Arpita Dutt
The lawsuit and the DoJ antitrust probe pose headline risk for generic companies like Mylan (MYL) and Teva (TEVA).
Generic Stocks Feel Pricing Heat, 1st Charges Filed in DoJ Antitrust Probe
by Arpita Dutt
Key generic drugmakers including Teva (TEVA) saw their shares slip on news that the first charges have been filed in the investigation related to generic drug pricing.
Bull of the Day: Lannett (LCI)
by Tracey Ryniec
This generic drug maker is a rare value AND growth stock.
Profit Margins Will Determine Your Portfolio's Bottom Line
by Kevin Matras
Kevin Matras looks at the powerful combination of Sales Growth and Increasing Profit Margins. Highlighted stocks include EXR, HF, LCI, MCO and WRB.